| Name | Title | Contact Details |
|---|
Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.
Leeway Inc is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in New Haven, CT. To find more information about Leeway Inc, please visit www.leeway.net
Visiting Nurse and Community Health is a Arlington, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Transhealth is a Brentwood, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The American Physical Therapy Associations top-ranked private physical therapy practice, and the top-rated physical therapists in New York City.